AI in Drug Discovery Market Size, Industry Report by Business Opportunity, Global Trend, Future Grow
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
AI for Drug Discovery Market 2021 Expertise Research Emerging Trends, Top Market Leaders and Top to Bottom Analysis Till 2027 | Atomwise, Inc ,Insilico Medicine,BIOAGE,Numerate,NuMedii, Inc ,Envisagenics & More
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
AI for Drug Discovery Market May Set New Growth Story | Atomwise, Insilico Medicine, BIOAGE, Envisagenics
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
Data Bridge Market Research analyses the market to account to USD 3,932.87 million by 2027 36
Artificial intelligence (AI) in drug discovery market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 3,932.87 million by 2027 growing at a CAGR of 40.5% in the above-mentioned forecast period. The growing awareness amongst the physicians and patients regarding the benefits of artificial intelligence has been directly impacting the growth of the market.
The major players covered in the artificial intelligence (AI) in drug discovery market report are
Microsoft, NVIDIA Corporation, IBM Corporation, Atomwise, Inc., DEEP GENOMICS, Cloud Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI Ltd, Exscientia, Cyclica Inc., Numerate, NuMedii, Inc., Envisagenics., twoXAR, Incorporated, OWKIN, INC., XtalPi Inc., BERG LLC, among other domestic and global players.